{"transactions":[{"id":1825579,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":111240,"kind":"person","name":"Rimac Anthony M","position":1,"cik":"0001604562","reported_name":"Rimac Anthony M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:18:20.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":242142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this option shall vest and become exercisable on April 10, 2024, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":242142,"derivative":{"exercise_price":13.51,"expiration_date":"2033-04-19","underlying":"Series A Common Stock","underlying_shares":242142},"source":{"system":"sec-edgar","filing":"0001104659-23-082730","document":"tm2321276-19_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082730/tm2321276-19_4seq1.xml","form_type":"4"}},{"id":1825578,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":111240,"kind":"person","name":"Rimac Anthony M","position":1,"cik":"0001604562","reported_name":"Rimac Anthony M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:18:20.000Z","date":"2023-07-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":242142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this option shall vest and become exercisable on April 10, 2024, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":13.51,"expiration_date":"2033-04-19","underlying":"Common Stock","underlying_shares":242142},"source":{"system":"sec-edgar","filing":"0001104659-23-082730","document":"tm2321276-19_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923082730/tm2321276-19_4seq1.xml","form_type":"4"}}]}